Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $2.31 billion. The enterprise value is $1.74 billion.
Important Dates
The last earnings date was Friday, February 21, 2025, before market open.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 59.60 million shares outstanding. The number of shares has increased by 14.65% in one year.
| Current Share Class | 59.60M |
| Shares Outstanding | 59.60M |
| Shares Change (YoY) | +14.65% |
| Shares Change (QoQ) | +7.51% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 88.50% |
| Float | 47.50M |
Valuation Ratios
The trailing PE ratio is 9.16.
| PE Ratio | 9.16 |
| Forward PE | n/a |
| PS Ratio | 5.49 |
| Forward PS | 15.34 |
| PB Ratio | 4.34 |
| P/TBV Ratio | 4.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 6.31 |
| EV / Sales | 4.00 |
| EV / EBITDA | 6.84 |
| EV / EBIT | 6.87 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 63.36% and return on invested capital (ROIC) is 35.89%.
| Return on Equity (ROE) | 63.36% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 35.89% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $3.88M |
| Profits Per Employee | $2.46M |
| Employee Count | 112 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $4.22 million in taxes.
| Income Tax | 4.22M |
| Effective Tax Rate | 1.51% |
Stock Price Statistics
The stock price has increased by +42.31% in the last 52 weeks. The beta is 2.21, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.21 |
| 52-Week Price Change | +42.31% |
| 50-Day Moving Average | 38.64 |
| 200-Day Moving Average | 39.23 |
| Relative Strength Index (RSI) | 52.47 |
| Average Volume (20 Days) | 528,595 |
Short Selling Information
The latest short interest is 3.79 million, so 6.36% of the outstanding shares have been sold short.
| Short Interest | 3.79M |
| Short Previous Month | 3.67M |
| Short % of Shares Out | 6.36% |
| Short % of Float | 7.99% |
| Short Ratio (days to cover) | 6.91 |
Income Statement
In the last 12 months, PTGX had revenue of $434.43 million and earned $275.19 million in profits. Earnings per share was $4.23.
| Revenue | 434.43M |
| Gross Profit | 434.43M |
| Operating Income | 252.84M |
| Pretax Income | 172.60M |
| Net Income | 275.19M |
| EBITDA | 253.79M |
| EBIT | 252.84M |
| Earnings Per Share (EPS) | $4.23 |
Full Income StatementBalance Sheet
The company has $468.72 million in cash and $10.90 million in debt, giving a net cash position of $572.38 million or $9.60 per share.
| Cash & Cash Equivalents | 468.72M |
| Total Debt | 10.90M |
| Net Cash | 572.38M |
| Net Cash Per Share | $9.60 |
| Equity (Book Value) | 531.92M |
| Book Value Per Share | 8.94 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 58.20% and 63.34%.
| Gross Margin | 100.00% |
| Operating Margin | 58.20% |
| Pretax Margin | 64.32% |
| Profit Margin | 63.34% |
| EBITDA Margin | 58.42% |
| EBIT Margin | 58.20% |
| FCF Margin | n/a |